Company Filing History:
Years Active: 1995-2002
Title: The Innovative Contributions of Yi Bin Xiang
Introduction
Yi Bin Xiang is a notable inventor based in Acton, MA (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of five patents to his name, he has made strides in developing compounds that address critical health issues.
Latest Patents
Among his latest patents, Yi Bin Xiang has developed triazine antiviral compounds. This invention provides pharmaceutical formulations comprising 1,3,5-triazine derivatives, which exhibit a range of activities, including antiviral and antibiotic properties. These formulations can be utilized alone or in combination as a method of treating patients in need of antiviral and/or antibiotic therapy. The triazine derivatives bind to and inhibit functional nucleic acids, demonstrating broad applicability in treating conditions associated with DNA and RNA viruses. Additionally, he has disclosed hydrazone, hydrazine, and thiosemicarbazone derivatives as antifungal agents. This patent includes pharmaceutical compositions comprising aryl and heteroaryl derivatives, along with methods for using these compositions to alleviate fungal infections.
Career Highlights
Yi Bin Xiang has worked with several prominent companies in the pharmaceutical industry, including Scriptgen Pharmaceuticals, Inc. and Anadys Pharmaceuticals, Inc. His work has focused on innovative solutions to combat viral and fungal infections, showcasing his commitment to advancing medical science.
Collaborations
Some of his notable coworkers include Vincent Boyd and Kelvin T Lam, who have collaborated with him on various projects throughout his career.
Conclusion
Yi Bin Xiang's contributions to pharmaceutical innovations highlight his dedication to improving health outcomes through his inventive work. His patents reflect a deep understanding of complex biological challenges and a commitment to finding effective solutions.